JP2007502139A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007502139A5 JP2007502139A5 JP2006523081A JP2006523081A JP2007502139A5 JP 2007502139 A5 JP2007502139 A5 JP 2007502139A5 JP 2006523081 A JP2006523081 A JP 2006523081A JP 2006523081 A JP2006523081 A JP 2006523081A JP 2007502139 A5 JP2007502139 A5 JP 2007502139A5
- Authority
- JP
- Japan
- Prior art keywords
- delivery device
- drug delivery
- hollow tube
- open end
- sealing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012377 drug delivery Methods 0.000 claims 35
- 229920002635 polyurethane Polymers 0.000 claims 18
- 239000004814 polyurethane Substances 0.000 claims 18
- 238000007789 sealing Methods 0.000 claims 16
- 239000000203 mixture Substances 0.000 claims 15
- 229920001187 thermosetting polymer Polymers 0.000 claims 14
- 239000004480 active ingredient Substances 0.000 claims 12
- 238000009472 formulation Methods 0.000 claims 11
- 229920000642 polymer Polymers 0.000 claims 10
- 230000002209 hydrophobic effect Effects 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 7
- 238000002360 preparation method Methods 0.000 claims 7
- 238000000034 method Methods 0.000 claims 6
- 239000002609 medium Substances 0.000 claims 5
- 239000004433 Thermoplastic polyurethane Substances 0.000 claims 4
- 239000013543 active substance Substances 0.000 claims 4
- 229920002803 thermoplastic polyurethane Polymers 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 238000000465 moulding Methods 0.000 claims 3
- 239000008188 pellet Substances 0.000 claims 3
- 239000004970 Chain extender Substances 0.000 claims 2
- 239000012736 aqueous medium Substances 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000001033 ether group Chemical group 0.000 claims 2
- HHXHVIJIIXKSOE-QILQGKCVSA-N histrelin Chemical group CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC(N=C1)=CN1CC1=CC=CC=C1 HHXHVIJIIXKSOE-QILQGKCVSA-N 0.000 claims 2
- 239000011796 hollow space material Substances 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 230000000977 initiatory effect Effects 0.000 claims 2
- 238000001746 injection moulding Methods 0.000 claims 2
- 125000003010 ionic group Chemical group 0.000 claims 2
- 230000004526 pharmaceutical effect Effects 0.000 claims 2
- 239000006187 pill Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 238000004528 spin coating Methods 0.000 claims 2
- 230000009885 systemic effect Effects 0.000 claims 2
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 claims 1
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 claims 1
- 102100024028 Progonadoliberin-1 Human genes 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 claims 1
- 239000000150 Sympathomimetic Substances 0.000 claims 1
- 239000000556 agonist Substances 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 claims 1
- 229940035674 anesthetics Drugs 0.000 claims 1
- 230000000507 anthelmentic effect Effects 0.000 claims 1
- 229940124339 anthelmintic agent Drugs 0.000 claims 1
- 239000000921 anthelmintic agent Substances 0.000 claims 1
- 230000001773 anti-convulsant effect Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 230000000648 anti-parkinson Effects 0.000 claims 1
- 230000002921 anti-spasmodic effect Effects 0.000 claims 1
- 229940125681 anticonvulsant agent Drugs 0.000 claims 1
- 239000001961 anticonvulsive agent Substances 0.000 claims 1
- 239000003430 antimalarial agent Substances 0.000 claims 1
- 229940033495 antimalarials Drugs 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000000939 antiparkinson agent Substances 0.000 claims 1
- 229940124575 antispasmodic agent Drugs 0.000 claims 1
- 230000001588 bifunctional effect Effects 0.000 claims 1
- -1 cardiovascular Substances 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 229960002896 clonidine Drugs 0.000 claims 1
- 230000003750 conditioning effect Effects 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- 238000004132 cross linking Methods 0.000 claims 1
- 239000003431 cross linking reagent Substances 0.000 claims 1
- 125000005442 diisocyanate group Chemical group 0.000 claims 1
- 239000002934 diuretic Substances 0.000 claims 1
- 229940030606 diuretics Drugs 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 238000005538 encapsulation Methods 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 239000003193 general anesthetic agent Substances 0.000 claims 1
- XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 claims 1
- 229960002193 histrelin Drugs 0.000 claims 1
- 108700020746 histrelin Proteins 0.000 claims 1
- 229960003911 histrelin acetate Drugs 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 239000003999 initiator Substances 0.000 claims 1
- 239000012948 isocyanate Substances 0.000 claims 1
- 150000002513 isocyanates Chemical class 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 239000003158 myorelaxant agent Substances 0.000 claims 1
- DQCKKXVULJGBQN-XFWGSAIBSA-N naltrexone Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)O)CC1)O)CC1CC1 DQCKKXVULJGBQN-XFWGSAIBSA-N 0.000 claims 1
- 229960003086 naltrexone Drugs 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 230000037452 priming Effects 0.000 claims 1
- 229940001470 psychoactive drug Drugs 0.000 claims 1
- 239000004089 psychotropic agent Substances 0.000 claims 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 230000001975 sympathomimetic effect Effects 0.000 claims 1
- 229940064707 sympathomimetics Drugs 0.000 claims 1
- 229940125725 tranquilizer Drugs 0.000 claims 1
- 239000003204 tranquilizing agent Substances 0.000 claims 1
- 230000002936 tranquilizing effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49413203P | 2003-08-11 | 2003-08-11 | |
| US60/494,132 | 2003-08-11 | ||
| CA2,437,639 | 2003-08-18 | ||
| CA2437639A CA2437639C (en) | 2003-08-11 | 2003-08-18 | Long term drug delivery devices with polyurethane based polymers and their manufacture |
| PCT/IB2004/002823 WO2005013936A2 (en) | 2003-08-11 | 2004-08-11 | Manufacture of long term drug delivery devices with polyurethane based polymers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011031294A Division JP5368497B2 (ja) | 2003-08-11 | 2011-02-16 | ポリウレタンを基とするポリマーを用いた長期薬物輸送装置の製造 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007502139A JP2007502139A (ja) | 2007-02-08 |
| JP2007502139A5 true JP2007502139A5 (https=) | 2008-08-07 |
| JP5060128B2 JP5060128B2 (ja) | 2012-10-31 |
Family
ID=34137163
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006523081A Expired - Fee Related JP5060128B2 (ja) | 2003-08-11 | 2004-08-11 | ポリウレタンを基とするポリマーを用いた長期薬物輸送装置の製造 |
| JP2011031294A Expired - Fee Related JP5368497B2 (ja) | 2003-08-11 | 2011-02-16 | ポリウレタンを基とするポリマーを用いた長期薬物輸送装置の製造 |
| JP2012219869A Pending JP2013049678A (ja) | 2003-08-11 | 2012-10-01 | ポリウレタン系ポリマーを用いた長期薬物輸送装置の製造 |
| JP2014164312A Pending JP2014237699A (ja) | 2003-08-11 | 2014-08-12 | ポリウレタン系ポリマーを用いた長期薬物輸送装置の製造 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011031294A Expired - Fee Related JP5368497B2 (ja) | 2003-08-11 | 2011-02-16 | ポリウレタンを基とするポリマーを用いた長期薬物輸送装置の製造 |
| JP2012219869A Pending JP2013049678A (ja) | 2003-08-11 | 2012-10-01 | ポリウレタン系ポリマーを用いた長期薬物輸送装置の製造 |
| JP2014164312A Pending JP2014237699A (ja) | 2003-08-11 | 2014-08-12 | ポリウレタン系ポリマーを用いた長期薬物輸送装置の製造 |
Country Status (16)
| Country | Link |
|---|---|
| US (6) | US7842303B2 (https=) |
| EP (3) | EP1660034B1 (https=) |
| JP (4) | JP5060128B2 (https=) |
| CN (2) | CN102133174B (https=) |
| AT (1) | ATE421316T1 (https=) |
| AU (3) | AU2004262999B2 (https=) |
| CA (1) | CA2437639C (https=) |
| DE (1) | DE602004019224D1 (https=) |
| DK (1) | DK1660034T3 (https=) |
| ES (1) | ES2320556T3 (https=) |
| HR (1) | HRP20090209T1 (https=) |
| MX (1) | MXPA06001612A (https=) |
| PL (1) | PL1660034T3 (https=) |
| PT (1) | PT1660034E (https=) |
| SI (1) | SI1660034T1 (https=) |
| WO (1) | WO2005013936A2 (https=) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7858110B2 (en) * | 2003-08-11 | 2010-12-28 | Endo Pharmaceuticals Solutions, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
| US20090208540A1 (en) * | 2003-08-11 | 2009-08-20 | Indevus Pharmaceuticals, Inc. | Implantable device for the delivery of naltrexone and methods of use thereof |
| CA2437639C (en) * | 2003-08-11 | 2016-07-05 | Valera Pharmaceuticals, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
| EP1773293B1 (en) | 2004-06-17 | 2015-04-15 | Endo Pharmaceuticals Solutions Inc. | Compositions and methods for treating central precocious puberty |
| US7759312B2 (en) * | 2005-03-11 | 2010-07-20 | Endo Pharmaceuticals Solutions Inc. | Delivery of dry formulations of octreotide |
| EP2455072A1 (en) * | 2005-03-11 | 2012-05-23 | Endo Pharmaceuticals Solutions Inc. | Controlled release formulations of octreotide |
| US8211060B2 (en) | 2005-05-10 | 2012-07-03 | Palyon Medical (Bvi) Limited | Reduced size implantable pump |
| US8114055B2 (en) | 2005-05-10 | 2012-02-14 | Palyon Medical (Bvi) Limited | Implantable pump with infinitely variable resistor |
| US7637892B2 (en) * | 2005-05-10 | 2009-12-29 | Palyon Medical (Bvi) Limited | Variable flow infusion pump system |
| US8915893B2 (en) | 2005-05-10 | 2014-12-23 | Palyon Medical (Bvi) Limited | Variable flow infusion pump system |
| MX2009011641A (es) * | 2007-04-27 | 2010-03-04 | Endo Pharmaceuticals Solutions | Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos. |
| US8303536B2 (en) * | 2007-08-30 | 2012-11-06 | Sunstorm Research Corp. | Implantable delivery device |
| US9775882B2 (en) * | 2007-09-20 | 2017-10-03 | Medtronic, Inc. | Medical devices and methods including polymers having biologically active agents therein |
| DK2207568T3 (en) | 2007-11-16 | 2017-09-18 | Univ Rockefeller | ANTIBODIES SPECIFIC TO THE PROTOFIBRILE FORM OF BETA AMYLOID PROTEIN |
| UA104866C2 (uk) * | 2008-06-25 | 2014-03-25 | Ендо Фармас'Ютікалз Солюшнз Інк. | Імплантат октреотиду, який містить вивільняючу речовину |
| WO2009158412A2 (en) | 2008-06-25 | 2009-12-30 | Endo Pharmaceuticals Solutions Inc. | Sustained delivery of exenatide and other polypeptides |
| CA2739180C (en) * | 2008-09-30 | 2017-12-19 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the delivery of octreotide and methods of use thereof |
| US20110236456A1 (en) * | 2008-09-30 | 2011-09-29 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the delivery of histrelin and methods of use thereof |
| CA2739181C (en) * | 2008-09-30 | 2017-03-14 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the delivery of risperidone and methods of use thereof |
| US20110097380A1 (en) * | 2009-10-28 | 2011-04-28 | Warsaw Orthopedic, Inc. | Clonidine formulations having antimicrobial properties |
| WO2011139594A2 (en) | 2010-04-27 | 2011-11-10 | Medtronic, Inc. | Artificial bursa for intra-articular drug delivery |
| CA2804032C (en) * | 2010-06-30 | 2018-05-01 | Evonik Degussa Corporation | Core-sheath implant device having an inner core lobe |
| US20190263888A1 (en) | 2010-10-19 | 2019-08-29 | Op-T Llc | Therapeutic peptides and methods for treating autoimmune related disease |
| WO2012177825A1 (en) | 2011-06-21 | 2012-12-27 | Bvw Holding Ag | Medical device comprising boswellic acid |
| WO2013013172A1 (en) * | 2011-07-20 | 2013-01-24 | The University Of Utah Research Foundation | Intravaginal devices for drug delivery |
| JP6149183B2 (ja) * | 2011-10-24 | 2017-06-21 | ブレイバーン ファーマシューティカルズ，インコーポレイティド | 移植可能チザニジン組成物及びその治療方法 |
| HUE032240T2 (en) | 2011-10-24 | 2017-09-28 | Asana Biosciences Llc | cyclohexylamines |
| US8568360B2 (en) | 2011-12-28 | 2013-10-29 | Palyon Medical (Bvi) Limited | Programmable implantable pump design |
| KR102557326B1 (ko) | 2013-03-15 | 2023-07-19 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 구성요소를 가지는 약물 전달 장치 |
| JP6616772B2 (ja) | 2013-12-16 | 2019-12-04 | アサナ・バイオサイエンシズ，リミテッド・ライアビリティ・カンパニー | Ｐ２ｘ３および／またはｐ２ｘ２／３化合物ならびに方法 |
| WO2016172704A1 (en) | 2015-04-23 | 2016-10-27 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| EP3316891B1 (en) | 2015-07-01 | 2019-10-16 | Region Nordjylland, Aalborg Universitetshospital | Treatment of otitis media with retroauricular injection of an anti-inflammatory drug |
| ES2970828T3 (es) | 2016-02-10 | 2024-05-30 | Univ Rutgers | Nuevos anticuerpos anti-lam |
| ITUA20162094A1 (it) * | 2016-03-29 | 2017-09-29 | Cid S P A | Perfezionamenti negli stent per il rilascio di principi attivi |
| WO2018044970A1 (en) | 2016-08-31 | 2018-03-08 | University Of Rochester | Human monoclonal antibodies to human endogenous retrovirus k envelope (herv-k) and uses thereof |
| CN109996546B (zh) | 2016-09-30 | 2023-06-27 | 阿沙纳生物科学公司 | P2x3和/或p2x2/3化合物及方法 |
| ES3031007T3 (en) * | 2017-11-10 | 2025-07-03 | Op T Llc | Peptide for preventing, modulating and/or reducing cardiovascular disease |
| AU2019362730B2 (en) | 2018-10-15 | 2022-10-20 | Chong Kun Dang Pharmaceutical Corp. | Injectable long-acting naltrexone microparticle compositions |
| CA3130212A1 (en) * | 2019-02-19 | 2020-08-27 | Particle Sciences, Inc. | Compartmentalized drug delivery devices |
| US11793854B2 (en) | 2019-03-21 | 2023-10-24 | Op-T Llc | Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction |
| CA3157003A1 (en) | 2019-10-07 | 2021-04-15 | Oak Crest Institute Of Science | Orally implantable drug delivery device |
| CN114980861A (zh) | 2019-11-27 | 2022-08-30 | 橡冠科学研究院 | 缓释药物递送装置 |
| US12048734B2 (en) | 2020-04-17 | 2024-07-30 | Op-T Llc | Bioactive peptides and methods of use thereof |
| CN112169138A (zh) * | 2020-10-30 | 2021-01-05 | 苏州伟康医疗器械有限公司 | 导尿管的堵头粘结工艺、导尿管 |
| US11820890B2 (en) | 2021-04-01 | 2023-11-21 | Stratasys Inc | Pulverulent thermoplastic polymer blends |
| US20250170254A1 (en) | 2022-01-06 | 2025-05-29 | Oak Crest Institute Of Science | Subdermal Implant for Sustained Drug Delivery |
| CN114715483B (zh) * | 2022-05-04 | 2023-09-26 | 展一智能科技(东台)有限公司 | 下封堵操作机构及包装箱整理机 |
| EP4698151A1 (en) | 2023-04-19 | 2026-02-25 | Oak Crest Institute of Science | Vaginal drug delivery device |
| WO2026055309A1 (en) | 2024-09-04 | 2026-03-12 | Oak Crest Institute Of Science | Subdermal drug delivery devices |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3993073A (en) | 1969-04-01 | 1976-11-23 | Alza Corporation | Novel drug delivery device |
| US3948254A (en) | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
| US3975350A (en) | 1972-08-02 | 1976-08-17 | Princeton Polymer Laboratories, Incorporated | Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles |
| US4136145A (en) * | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| US4207890A (en) | 1977-01-04 | 1980-06-17 | Mcneilab, Inc. | Drug-dispensing device and method |
| US4131604A (en) | 1977-11-23 | 1978-12-26 | Thermo Electron Corporation | Polyurethane elastomer for heart assist devices |
| US4207809A (en) * | 1978-03-20 | 1980-06-17 | Restaurant Technology, Inc. | Dual reservoir coffee urn |
| US4386039A (en) | 1980-02-11 | 1983-05-31 | Thermo Electron Corporation | Process for forming an optically clear polyurethane lens or cornea |
| US4523005A (en) | 1981-10-30 | 1985-06-11 | Thermedics, Inc. | Extrudable polyurethane for prosthetic devices prepared from a diisocyanate, a polytetramethylene ether polyol, and 1,4-butane diol |
| US4469671A (en) | 1983-02-22 | 1984-09-04 | Eli Lilly And Company | Contraceptive device |
| US4751133A (en) | 1984-11-13 | 1988-06-14 | Thermedics, Inc. | Medical patches and processes for producing same |
| US4673565A (en) | 1985-05-03 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Pharmaceutical compositions containing hollow fine tubular drug delivery systems |
| US4720384A (en) * | 1985-05-03 | 1988-01-19 | E. I. Du Pont De Nemours And Company | Manufacture of hollow fine tubular drug delivery systems |
| JPS62223112A (ja) | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
| US4743673A (en) | 1986-12-19 | 1988-05-10 | Tyndale Plains-Hunter, Ltd. | Hydrophilic carboxy polyurethanes |
| US5035891A (en) * | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
| US5207705A (en) * | 1988-12-08 | 1993-05-04 | Brigham And Women's Hospital | Prosthesis of foam polyurethane and collagen and uses thereof |
| US5254662A (en) | 1990-09-12 | 1993-10-19 | Polymedia Industries, Inc. | Biostable polyurethane products |
| AU651654B2 (en) | 1992-01-14 | 1994-07-28 | Endo Pharmaceuticals Solutions Inc. | Manufacture of water-swellable hydrophilic articles and drug delivery devices |
| US5266325A (en) | 1990-09-28 | 1993-11-30 | Hydro Med Science Division Of National Patent Development Corp. | Preparation of homogeneous hydrogel copolymers |
| JP2530079B2 (ja) * | 1992-02-05 | 1996-09-04 | ナショナル・パテント・ディベロプメント・コーポレーション | 水分膨潤性親水性製品及び薬物放出装置の製造 |
| CA2134087C (en) * | 1992-04-24 | 2007-07-17 | Robert S. Ward | Copolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight range |
| US5629008A (en) * | 1992-06-02 | 1997-05-13 | C.R. Bard, Inc. | Method and device for long-term delivery of drugs |
| US5354835A (en) | 1993-07-23 | 1994-10-11 | Saudi Basic Industries Corporation | Desalination process |
| US5626862A (en) * | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| WO1996024330A1 (en) * | 1995-02-10 | 1996-08-15 | Medtronic, Inc. | Method and device for administering analgesics |
| US5789411A (en) * | 1995-09-11 | 1998-08-04 | Lance L. Gooberman P. C. | Improvements to rapid opioid detoxification |
| ES2233768T3 (es) * | 1996-02-02 | 2005-06-16 | Alza Corporation | Liberacion prolongada de un agente activo utilizando un sistema implantable. |
| FR2752380B1 (fr) * | 1996-08-14 | 1998-10-30 | Dow Corning Sa | Procede de fabrication d'un dispositif a liberation controlee |
| AUPO251096A0 (en) | 1996-09-23 | 1996-10-17 | Cardiac Crc Nominees Pty Limited | Polysiloxane-containing polyurethane elastomeric compositions |
| US7728049B2 (en) * | 1996-10-08 | 2010-06-01 | Zamore Alan M | Irradiation conversion of thermoplastic to thermoset polymers |
| US20010006677A1 (en) * | 1996-10-29 | 2001-07-05 | Mcginity James W. | Effervescence polymeric film drug delivery system |
| MY125849A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
| US5880571A (en) | 1997-09-11 | 1999-03-09 | Sundstrand Corporation | Method of and system for controlling a variable speed induction motor |
| ES2182379T3 (es) * | 1997-12-22 | 2003-03-01 | Alza Corp | Membrana de regulacion del regimen de liberacion para dispositivos de administracion controlada de farmacos. |
| WO1999033449A1 (en) * | 1997-12-30 | 1999-07-08 | Alza Corporation | Beneficial agent delivery system with membrane plug |
| WO2001043726A1 (en) | 1999-12-16 | 2001-06-21 | Trident Technologies, Llc | System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| US7067116B1 (en) * | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
| WO2001074555A1 (en) * | 2000-03-31 | 2001-10-11 | Holy Norman L | Compostable, degradable plastic compositions and articles thereof |
| CA2420854C (en) * | 2000-09-01 | 2013-07-30 | Palmaya Pty Ltd | Slow release pharmaceutical preparation and method of administering of same |
| US6887270B2 (en) * | 2002-02-08 | 2005-05-03 | Boston Scientific Scimed, Inc. | Implantable or insertable medical device resistant to microbial growth and biofilm formation |
| AU2003228083A1 (en) * | 2002-05-23 | 2003-12-12 | Discure, Ltd. | Joint and dental implants |
| US7858110B2 (en) | 2003-08-11 | 2010-12-28 | Endo Pharmaceuticals Solutions, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
| CA2437639C (en) * | 2003-08-11 | 2016-07-05 | Valera Pharmaceuticals, Inc. | Long term drug delivery devices with polyurethane based polymers and their manufacture |
| US20090208540A1 (en) | 2003-08-11 | 2009-08-20 | Indevus Pharmaceuticals, Inc. | Implantable device for the delivery of naltrexone and methods of use thereof |
| PT1781264E (pt) | 2004-08-04 | 2013-10-16 | Evonik Corp | Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma |
| EP2455072A1 (en) | 2005-03-11 | 2012-05-23 | Endo Pharmaceuticals Solutions Inc. | Controlled release formulations of octreotide |
| US20080004260A1 (en) * | 2006-06-29 | 2008-01-03 | Transcept Pharmaceuticals, Inc. | Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions |
| MX2009005444A (es) * | 2006-11-22 | 2009-06-02 | Organon Nv | Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado. |
| US8956602B2 (en) | 2006-12-05 | 2015-02-17 | Landec, Inc. | Delivery of drugs |
| UA104866C2 (uk) | 2008-06-25 | 2014-03-25 | Ендо Фармас'Ютікалз Солюшнз Інк. | Імплантат октреотиду, який містить вивільняючу речовину |
| CA2739180C (en) | 2008-09-30 | 2017-12-19 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the delivery of octreotide and methods of use thereof |
| CA2739181C (en) | 2008-09-30 | 2017-03-14 | Endo Pharmaceuticals Solutions Inc. | Implantable device for the delivery of risperidone and methods of use thereof |
-
2003
- 2003-08-18 CA CA2437639A patent/CA2437639C/en not_active Expired - Fee Related
-
2004
- 2004-08-10 US US10/915,625 patent/US7842303B2/en not_active Expired - Fee Related
- 2004-08-11 DK DK04769233T patent/DK1660034T3/da active
- 2004-08-11 CN CN201110053656.6A patent/CN102133174B/zh not_active Expired - Fee Related
- 2004-08-11 JP JP2006523081A patent/JP5060128B2/ja not_active Expired - Fee Related
- 2004-08-11 HR HR20090209T patent/HRP20090209T1/xx unknown
- 2004-08-11 EP EP04769233A patent/EP1660034B1/en not_active Expired - Lifetime
- 2004-08-11 ES ES04769233T patent/ES2320556T3/es not_active Expired - Lifetime
- 2004-08-11 AU AU2004262999A patent/AU2004262999B2/en not_active Ceased
- 2004-08-11 EP EP08010973A patent/EP1982695A3/en not_active Ceased
- 2004-08-11 WO PCT/IB2004/002823 patent/WO2005013936A2/en not_active Ceased
- 2004-08-11 MX MXPA06001612A patent/MXPA06001612A/es active IP Right Grant
- 2004-08-11 PL PL04769233T patent/PL1660034T3/pl unknown
- 2004-08-11 CN CN2004800293420A patent/CN1863504B/zh not_active Expired - Fee Related
- 2004-08-11 PT PT04769233T patent/PT1660034E/pt unknown
- 2004-08-11 AT AT04769233T patent/ATE421316T1/de active
- 2004-08-11 DE DE602004019224T patent/DE602004019224D1/de not_active Expired - Lifetime
- 2004-08-11 SI SI200431052T patent/SI1660034T1/sl unknown
- 2004-08-11 EP EP14172031.8A patent/EP2805709A1/en not_active Withdrawn
-
2009
- 2009-07-22 AU AU2009202942A patent/AU2009202942B2/en not_active Ceased
-
2010
- 2010-08-31 US US12/873,130 patent/US8357389B2/en not_active Expired - Fee Related
- 2010-10-19 US US12/907,717 patent/US8343528B2/en not_active Expired - Fee Related
- 2010-12-14 AU AU2010251786A patent/AU2010251786B2/en not_active Ceased
-
2011
- 2011-02-16 JP JP2011031294A patent/JP5368497B2/ja not_active Expired - Fee Related
-
2012
- 2012-10-01 JP JP2012219869A patent/JP2013049678A/ja active Pending
- 2012-12-04 US US13/693,659 patent/US8529936B2/en not_active Expired - Fee Related
-
2013
- 2013-07-26 US US13/952,327 patent/US8658195B2/en not_active Expired - Fee Related
-
2014
- 2014-01-20 US US14/159,119 patent/US20140135684A1/en not_active Abandoned
- 2014-08-12 JP JP2014164312A patent/JP2014237699A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007502139A5 (https=) | ||
| JP5060128B2 (ja) | ポリウレタンを基とするポリマーを用いた長期薬物輸送装置の製造 | |
| ES2255266T3 (es) | Procedimiento de fabricacion por moldeo po inyeccion para dispositivos de liberacion controlada y dispositivo asi producido. | |
| Zema et al. | Injection molding and its application to drug delivery | |
| US8728521B2 (en) | Physically/molecularly distributed and/or chemically bound medicaments in empty, hard capsule shells | |
| US11426571B2 (en) | Microneedle array with composite formulation, and method for manufacturing same | |
| CN112074227A (zh) | 用于经皮和脉冲药物/疫苗递送的核壳微针平台及其制造方法 | |
| WO2004112748A3 (en) | Rate controlled release of a pharmaceutical agent in a biodegradable device | |
| KR101828591B1 (ko) | Ccdp 방법에 의한 마이크로구조체의 제조 | |
| Melchels et al. | Initial design and physical characterization of a polymeric device for osmosis‐driven delayed burst delivery of vaccines | |
| CN205903442U (zh) | 基于3d打印技术的新型缓释微球 | |
| US20180193536A1 (en) | Bioresorbable drug delivery matrices based on cross-linked polysaccharides, dosage forms designed for delayed/controlled release | |
| WO2024107541A1 (en) | Biodegradable fuse-and-reservoir system for the pulsed delivery of bioactive agents | |
| HK1124550A (en) | Manufacture of long term drug delivery devices with polyurethane | |
| HK1091145B (en) | Manufacture of long term drug delivery devices with polyurethane based polymers | |
| US20050112190A1 (en) | Dosage form for controlled release of an active agent formulation | |
| 이배훈 et al. | Synthesis and Characterzation of Thermosensitive Polyphosphazene Gels having a Functional Group |